CAREDX, INC. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- CAREDX, INC. payments for repurchase of common stock for the quarter ending 2025-12-31 was $12.21M.
- CAREDX, INC. payments for repurchase of common stock for the quarter ending 2025-09-30 was $25.56M.
- CAREDX, INC. payments for repurchase of common stock for the quarter ending 2025-06-30 was $50.00M.
- CAREDX, INC. payments for repurchase of common stock for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- CAREDX, INC. payments for repurchase of common stock for fiscal 2025 was $87.77M, a 16713.79% increase from fiscal 2024.
- CAREDX, INC. payments for repurchase of common stock for fiscal 2024 was $522.00K, a 98.10% decline from fiscal 2023.
- CAREDX, INC. payments for repurchase of common stock for fiscal 2023 was $27.54M, a 4189.88% increase from fiscal 2022.
- CAREDX, INC. payments for repurchase of common stock for fiscal 2022 was $642.00K.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2025-12-31 | $12.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $87.77M 10-K · filed 2026-02-25 |
| 2025-09-30 | $25.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $75.56M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $50.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $50.00M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $0.00 10-Q · filed 2025-04-30 | $0.00 derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $522.00K 10-K · filed 2026-02-25 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $26.49M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $27.31M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $522.00K 10-Q · filed 2025-04-30 | $27.37M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $25.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $27.54M 10-K · filed 2026-02-25 |
| 2023-09-30 | $814.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $2.21M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $67.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $1.40M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $690.00K 10-Q · filed 2024-05-09 | $1.33M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $642.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $642.00K 10-K · filed 2025-02-28 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-10 | |
| 2021-12-31 | $0.00 10-K · filed 2024-02-28 | |
| 2020-12-31 | $0.00 10-K · filed 2023-02-27 | |
| 2018-09-30 | $556.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |